Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Baxter
Deloitte
Fuji
UBS
Cipla
US Army
Cantor Fitzgerald
Express Scripts

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091632

« Back to Dashboard

NDA 091632 describes HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX, which is a drug marketed by Tris Pharma Inc and is included in one NDA. It is available from two suppliers. Additional details are available on the HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX profile page.

The generic ingredient in HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX is chlorpheniramine polistirex; hydrocodone polistirex. There are twenty-nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the chlorpheniramine polistirex; hydrocodone polistirex profile page.
Summary for 091632
Pharmacology for NDA: 091632
Suppliers and Packaging for NDA: 091632
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX chlorpheniramine polistirex; hydrocodone polistirex SUSPENSION, EXTENDED RELEASE;ORAL 091632 ANDA Atlantic Biologicals Corps 17856-0235 N 17856-0235-1
HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX chlorpheniramine polistirex; hydrocodone polistirex SUSPENSION, EXTENDED RELEASE;ORAL 091632 ANDA Tris Pharma Inc 27808-086 N 27808-086-02

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION, EXTENDED RELEASE;ORALStrengthEQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML
Approval Date:Oct 1, 2010TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
AstraZeneca
Fuji
Argus Health
UBS
Dow
Moodys
Cipla
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.